InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,709.20
(
0.15%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.21
(
1.00%
)
Bitcoin
62,816.33
(
2.23%
)
Post# of 251809
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

CHM_760

Send PM Follow Ignore
Followers 21
Posts 2070
Boards Moderated 0
Alias Born 02/09/2006

CHM_760

Re: None

Wednesday, 09/02/2015 12:57:59 PM

Wednesday, September 02, 2015 12:57:59 PM

Post# of 251809
TrovaGene Looks To Revolutionize The Cancer Diagnostic Market

Nice little writeup by Jason Napodano, if anyone is interested.

http://seekingalpha.com/article/3482186-trovagene-looks-to-revolutionize-the-cancer-diagnostic-market?auth_param=ioo:1aue8md:b798fa08ff633878b4efbea5f0ad6abe&uprof=11

Summary

TrovaGene is pioneering a new field of cancer diagnostics by using a urine-based liquid biopsy platform.
The company has a number of CLIA available tests on the market and expects to spend the next few months collecting data and seeking reimbursement from payers.
So far the rollout looks to be going very well, but it is still early in the launch.
Nevertheless, despite being early I see significant potential for the company's platform I believe the shares are undervalued as of today.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up